Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Placebo-Controlled, Double-Blind Crossover Study to Assess Psychological Effects of MDMA When Administered to Healthy Volunteers

NCT01404754 is registered in ClinicalTrials.gov with Resilient Pharmaceuticals as lead sponsor.

NCT NCT01404754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01404754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Placebo-Controlled, Double-Blind Crossover Study to Assess Psychological Effects of MDMA When Administered to Healthy Volunteers
Lead sponsor
Resilient Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
April 9, 2011
Completion date
August 5, 2022
Enrollment
107 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

psychological effects of study drug